lithium has been researched along with olanzapine in 69 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (5.80) | 18.2507 |
2000's | 41 (59.42) | 29.6817 |
2010's | 15 (21.74) | 24.3611 |
2020's | 9 (13.04) | 2.80 |
Authors | Studies |
---|---|
Tohen, M; Zarate, CA | 1 |
DeGolia, SG; Dunai, M; Ketter, TA; Strong, CM; Tate, DL; Winsberg, ME | 1 |
Grundy, S; Tohen, M | 1 |
Berk, M; Brook, S; Ichim, L | 1 |
Ghaemi, SN; Guille, C; Sachs, GS | 1 |
Nemeroff, CB | 1 |
Ghaemi, SN | 1 |
Gundlapalli, SP; Iqbal, MM; Passman, TE; Ryals, T; Ryan, WG | 1 |
Gibson, PJ; Greaney, MG; Grundy, SL; Namjoshi, MA; Sanger, TM; Tohen, MF | 1 |
Grace, JJ; Narendran, R; Pato, MT; Pristach, CA; Valenti, AM; Young, CM | 1 |
Flockhart, DA; Rosebraugh, CJ; Woosley, RL; Yasuda, SU | 1 |
Yatham, LN | 1 |
Meyer, JM | 1 |
Fossion, P; Paquet, V; Pelc, I; Servais, L; Strul, J | 1 |
Fernandez-Corres, B; Gonzalez-Pinto, A; Gutierrez, M; Lalaguna, B; Micó, JA; Pérez-Heredia, JL; Tohen, M | 1 |
Berry, N; Gupta, SK; Pradhan, S; Sagar, R | 1 |
Schatzberg, AF | 2 |
Manning, JS | 1 |
Grof, P | 1 |
Iwazaki, H | 1 |
Basile, VS; Kennedy, SH; Mancini, DA; McIntyre, RS; Srinivasan, J | 1 |
Baker, JD; Hirschfeld, RM; Sommerville, KW; Tracy, K; Wozniak, P | 1 |
Dittmann, S; Grunze, H | 1 |
Baker, RW; Bowden, CL; Calabrese, JR; Chengappa, KN; Evans, AR; Feldman, PD; Ghaemi, SN; Kupfer, DJ; Risser, RC; Sachs, GS; Suppes, T; Tohen, M; Zarate, CA | 1 |
Bagnall, AM; Bridle, C; Darba, J; Duffy, S; Palmer, S; Riemsma, R; Sculpher, M | 1 |
Kass, E; Klein, RM; Lewis, FT | 1 |
Ghaemi, SN; Hsu, DJ; Pardo, TB | 1 |
Oral, ET; Vahip, S | 1 |
Baldessarini, RJ; Calabrese, JR; Colom, F; Hennen, J; Martínez-Arán, A; Sánchez-Moreno, J; Tohen, M; Vieta, E; Yatham, LN | 1 |
Kennedy, SH; Konarski, JZ; Mancini, DA; McCann, S; McIntyre, RS; Srinivasan, J | 1 |
Keck, PE | 1 |
Baker, RW; Bowden, CL; Calabrese, JR; Cassano, GB; Crane, H; Dell'Osso, L; Dossenbach, MR; Evans, AR; Greil, W; Grunze, H; Koukopoulos, A; Licht, RW; Oerlinghausen, BM; Risser, R; Sachs, GS; Tohen, M; Yatham, LN | 1 |
Abay, E; Erdogan, E; Tuglu, C | 1 |
Danielyan, A; Kowatch, RA | 1 |
Adams, DH; Houston, JP; Ketter, TA; Meyers, AL; Risser, RC; Tohen, M; Williamson, DJ | 1 |
Arora, M; Praharaj, SK | 1 |
Gourion, D; Mouaffak, F | 1 |
Ebinger, M; Knetsch, I; Rosenhagen, MC; Schmidt, U; Weber, F; Winkelmann, J | 1 |
Ahl, J; Baldessarini, RJ; Houston, JP; Kaiser, CJ; Meyers, AL; Tohen, M | 1 |
Barbieri, M; Beynon, S; Bravo Vergel, Y; Duffy, S; Dunn, G; Geddes, J; Gilbody, S; Palmer, S; Soares-Weiser, K; Woolacott, N | 1 |
Hammonds, MD; Shim, SS | 1 |
Colom, F; Girardi, P; Kotzalidis, GD; Mazzarini, L; Pacchiarotti, I; Sanchez-Moreno, J; Vieta, E | 1 |
Deberdt, W; Greil, W; Ketter, T; Licht, RW; Lipkovich, IA; Severus, WE; Tohen, M; Young, AH | 1 |
Glue, P; Herbison, P; Tarr, GP | 1 |
Fisar, Z; Hroudová, J; Raboch, J | 1 |
Degenhardt, EK; Gatz, JL; Jacob, J; Tohen, M | 1 |
Higuchi, T; Kanba, S; Katagiri, H; Takahashi, M; Takita, Y; Tohen, M | 1 |
Eppendorfer, S; Grunze, H; Henneges, C; Hundemer, HP; Kraemer, S; Minarzyk, A; Wilhelm, S | 1 |
Bahk, WM; Kim, MD; Kwon, YJ; Lee, HB; Lee, JG; Woo, YS; Yoon, BH | 1 |
Fusté, M; Gill, G; Haro, JM; Meléndez-Pérez, I; Pinacho, R; Ramos, B; Saia, G; Villalta-Gil, V | 1 |
Baruch, P; Beaulieu, S; Bond, DJ; da Cunha, A; Daigneault, A; Dias, R; Kapczinski, F; Kauer-Sant'Anna, M; Kunz, M; Lafer, B; Lam, RW; Milev, R; Parikh, SV; Qian, H; Quevedo, J; Schaffer, A; Sharma, V; Silverstone, PH; Walji, N; Wong, H; Yatham, LN; Young, LT | 1 |
Berk, M; Conus, P; Cotton, SM; Hallam, K; Hasty, MK; Kader, L; Lambert, M; Macneil, C; McGorry, PD; Murphy, BP | 1 |
Karanti, A; Kardell, M; Landén, M; Lundberg, U | 1 |
Abbasi, Y; Foulser, P; Mathilakath, A; Nilforooshan, R | 1 |
Nurchi, AM; Pinna, AP; Podda, F; Ripoli, C; Tronci, MG; Zanni, R | 1 |
Carvalho, AF; Hidalgo-Mazzei, D; Murru, A; Pacchiarotti, I; Samalin, L; Verdolini, N; Vieta, E; Young, AH | 1 |
Aguiar-Ribeiro, EM; Assmann, CE; Azzolin, VF; Barbisan, F; da Cruz Jung, IE; da Cruz, IBM; do Prado-Lima, PAS; Duarte, MMMF; Fernandes, MS; Riffel, RT; Teixeira, CF | 1 |
Kazah, N; Peña-Salazar, C | 1 |
Bauer, M; Bohlken, J; Kostev, K; Riedel-Heller, S | 1 |
Ferreira, A; Gouverneur, A; Morival, C; Pageot, C; Pariente, A; Tournier, M | 1 |
Bakker, IM; Kamphuis, J; Schoevers, RA; Smith-Apeldoorn, SY; Touw, DJ; Veraart, JKE; Visser, BAE | 1 |
Baldessarini, RJ; Gaudiot, CES; Nestsiarovich, A; Tohen, M; Vieta, E; Zhu, Y | 1 |
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Nomura, I; Okuya, M; Sakuma, K | 1 |
Berk, M; Bortolasci, CC; Dean, OM; Gray, L; Kidnapillai, S; Kim, JH; Liu, ZSJ; McGee, SL; Panizzutti, B; Richardson, MF; Spolding, B; Swinton, C; Truong, TTT; Walder, K | 1 |
Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J | 1 |
Arslan, MA; Bilgici, B; Gümrükçüoğlu, Tİ; Karaustaoğlu, A; Tunçel, ÖK | 1 |
28 review(s) available for lithium and olanzapine
Article | Year |
---|---|
Antipsychotic agents and bipolar disorder.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Clozapine; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Lithium; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Treatment Outcome | 1998 |
Management of acute mania.
Topics: Acute Disease; Algorithms; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Humans; Lithium; Olanzapine; Pirenzepine; Research Design; Risk Factors; Treatment Outcome; Treatment Refusal; Valproic Acid | 1999 |
An ever-increasing pharmacopoeia for the management of patients with bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Electroconvulsive Therapy; Electromagnetic Phenomena; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Lithium; Olanzapine; Pirenzepine; Risperidone; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2000 |
New treatments for bipolar disorder: the role of atypical neuroleptic agents.
Topics: Acute Disease; Algorithms; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Humans; Lithium; Olanzapine; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Treatment Outcome; Valproic Acid | 2000 |
Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants.
Topics: Abnormalities, Drug-Induced; Acetates; Adult; Amines; Antimanic Agents; Benzodiazepines; Breast Feeding; Carbamazepine; Cyclohexanecarboxylic Acids; Female; Fetus; Gabapentin; gamma-Aminobutyric Acid; Haloperidol; Humans; Infant, Newborn; Lithium; Mood Disorders; Olanzapine; Pirenzepine; Placenta; Pregnancy; Risk Factors; Valproic Acid | 2001 |
The role of novel antipsychotics in bipolar disorders.
Topics: Acute Disease; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Haloperidol; Humans; Lithium; Olanzapine; Pirenzepine; Randomized Controlled Trials as Topic; Risperidone | 2002 |
Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnosis, Differential; Drug Therapy, Combination; Humans; Lithium; Male; Neuroleptic Malignant Syndrome; Olanzapine; Pirenzepine | 2003 |
New approaches to managing psychotic depression.
Topics: Affective Disorders, Psychotic; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Drug Therapy, Combination; Electroconvulsive Therapy; Fluoxetine; Humans; Lithium; Mifepristone; Olanzapine; Pirenzepine; Receptors, Glucocorticoid; Treatment Outcome | 2003 |
Difficult-to-treat depressions: a primary care perspective.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Lithium; Medical Records; Olanzapine; Pirenzepine; Primary Health Care; Psychotherapy | 2003 |
Selecting effective long-term treatment for bipolar patients: monotherapy and combinations.
Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Drug Therapy, Combination; Humans; Lamotrigine; Lithium; Long-Term Care; Olanzapine; Pirenzepine; Treatment Outcome; Triazines | 2003 |
[Manic phase (manic episode)].
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Electroconvulsive Therapy; Humans; Lithium; Olanzapine; Pirenzepine; Psychotherapy; Reference Standards; Valproic Acid | 2003 |
The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Tolerance; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Randomized Controlled Trials as Topic; Severity of Illness Index; Titrimetry; Treatment Outcome; Valproic Acid | 2003 |
[Treatment of acute bipolar disorder. Intriguing balancing act between mania and depression].
Topics: Acute Disease; Algorithms; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Isotopes; Lamotrigine; Lithium; Olanzapine; Pirenzepine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Triazines; Valproic Acid | 2003 |
A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cost-Benefit Analysis; Dibenzothiazepines; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Valproic Acid | 2004 |
An overview of primary care assessment and management of bipolar disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnostic Errors; Humans; Lamotrigine; Lithium; Olanzapine; Primary Health Care; Triazines; Valproic Acid | 2004 |
Strategies for preventing the recurrence of bipolar disorder.
Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Bipolar Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Therapy, Combination; Humans; Lamotrigine; Lithium; Olanzapine; Patient Education as Topic; Psychotherapy; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Triazines; Valproic Acid | 2004 |
Bipolar depression: an overview.
Topics: Acute Disease; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Chemoprevention; Contraindications; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Humans; Lamotrigine; Lithium; Olanzapine; Triazines; Valproic Acid | 2004 |
Employing pharmacologic treatment of bipolar disorder to greatest effect.
Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Lamotrigine; Lithium; Olanzapine; Receptors, GABA; Receptors, Glutamate; Treatment Outcome; Triazines; Valproic Acid | 2004 |
The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.
Topics: Acute Disease; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Double-Blind Method; Humans; Lithium; Olanzapine; Piperazines; Placebos; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome | 2005 |
Management options for bipolar disorder in children and adolescents.
Topics: Adolescent; Benzodiazepines; Bipolar Disorder; Carbamazepine; Child; Clozapine; Dibenzothiazepines; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Risperidone; Valproic Acid | 2005 |
A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cognitive Behavioral Therapy; Cost-Benefit Analysis; Databases, Bibliographic; Female; Humans; Lamotrigine; Lithium; Male; Models, Economic; Olanzapine; Outcome and Process Assessment, Health Care; Randomized Controlled Trials as Topic; Secondary Prevention; Triazines; Valproic Acid | 2007 |
Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania--a systematic review and meta-analysis.
Topics: Affect; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Humans; Lithium; Lithium Carbonate; Lithium Compounds; Mood Disorders; Olanzapine; Randomized Controlled Trials as Topic; Valproic Acid | 2011 |
The efficacy and safety of switching to ziprasidone from olanzapine in patients with bipolar I disorder: an 8-week, multicenter, open-label study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Substitution; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Thiazoles; Treatment Outcome; Valproic Acid; Young Adult | 2013 |
Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Lithium; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Thiazoles; Valproic Acid | 2018 |
Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Depression; Drug Interactions; Female; Haloperidol; Humans; Ketamine; Lithium; Male; Olanzapine; Psychotropic Drugs; Risperidone; Schizophrenia; Treatment Outcome | 2021 |
Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone | 2022 |
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Haloperidol; Humans; Lithium; Male; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tamoxifen; Valproic Acid | 2022 |
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzocycloheptenes; Haloperidol; Humans; Lithium; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Piperazines; Quetiapine Fumarate; Risperidone; Tamoxifen; Thiazoles; Valproic Acid | 2022 |
16 trial(s) available for lithium and olanzapine
Article | Year |
---|---|
Olanzapine compared to lithium in mania: a double-blind randomized controlled trial.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Prospective Studies; Psychiatric Status Rating Scales | 1999 |
A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Body Weight; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium; Male; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Treatment Outcome; Valproic Acid | 2000 |
Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep; Treatment Outcome; Weight Gain | 2001 |
Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.
Topics: Adult; Affective Disorders, Psychotic; Aged; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Brief Psychiatric Rating Scale; Cohort Studies; Depressive Disorder; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Treatment Outcome; Valproic Acid | 2001 |
Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Chemotherapy, Adjuvant; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Time Factors; Valproic Acid | 2002 |
Antipsychotic-induced weight gain: bipolar disorder and leptin.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Female; Humans; Leptin; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Risperidone; Valproic Acid; Weight Gain | 2003 |
The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Tolerance; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Randomized Controlled Trials as Topic; Severity of Illness Index; Titrimetry; Treatment Outcome; Valproic Acid | 2003 |
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
Topics: Adult; Aged; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lithium; Male; Middle Aged; Olanzapine; Recurrence; Time Factors; Valproic Acid | 2004 |
Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Longitudinal Studies; Male; Meta-Analysis as Topic; Olanzapine; Proportional Hazards Models; Psychiatric Status Rating Scales; Survival Analysis; Treatment Outcome | 2004 |
The antidepressant effects of risperidone and olanzapine in bipolar disorder.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Weight; Chemotherapy, Adjuvant; Depression; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pilot Projects; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Time Factors; Valproic Acid | 2004 |
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium; Longitudinal Studies; Male; Olanzapine; Psychiatric Status Rating Scales; Secondary Prevention; Treatment Outcome | 2005 |
Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Prognosis; Psychiatric Status Rating Scales; Secondary Prevention; Time Factors; Treatment Outcome | 2006 |
Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Placebos; Principal Component Analysis; Psychiatric Status Rating Scales; Risk Factors; Suicide; Treatment Outcome; Valproic Acid | 2006 |
Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
Topics: Adult; Affect; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Japan; Lithium; Male; Middle Aged; Olanzapine; Prolactin; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome; Valproic Acid | 2012 |
Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Combined Modality Therapy; Double-Blind Method; Female; Humans; Lithium; Male; Olanzapine; Risperidone; Time Factors; Weight Gain | 2016 |
Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: An 8-week randomised controlled trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Chlorpromazine; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Female; Humans; Lithium; Male; Olanzapine; Psychotic Disorders; Treatment Outcome | 2015 |
26 other study(ies) available for lithium and olanzapine
Article | Year |
---|---|
Rapid efficacy of olanzapine augmentation in nonpsychotic bipolar mixed states.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Thyroxine; Valproic Acid | 1998 |
Olanzapine-induced rhabdomyolysis.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Diagnosis, Differential; Electrocardiography; Humans; Lithium; Male; Olanzapine; Pirenzepine; Rhabdomyolysis | 2001 |
A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Weight; Diabetes Mellitus; Drug Therapy, Combination; Fasting; Female; Glucose Tolerance Test; Hospitalization; Humans; Hyperlipidemias; Lipid Metabolism; Lipids; Lithium; Male; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Pirenzepine; Retrospective Studies; Risperidone; Schizophrenia; Valproic Acid | 2002 |
Sleep-related eating disorder induced by olanzapine.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Feeding and Eating Disorders; Humans; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Sleep Wake Disorders; Somnambulism | 2002 |
[Fast control of manic or mixed episodes. Atypical neuroleptics for bipolar patients].
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Dopamine Antagonists; Drug Therapy, Combination; Haloperidol; Humans; Isotopes; Lithium; Olanzapine; Pirenzepine; Selective Serotonin Reuptake Inhibitors; Time Factors; Valproic Acid | 2003 |
[Long-term therapy with intuition].
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Drug Therapy, Combination; Hospitalization; Humans; Isotopes; Lithium; Olanzapine; Patient Readmission; Pirenzepine; Placebos; Recurrence; Selective Serotonin Reuptake Inhibitors; Time Factors; Valproic Acid | 2003 |
Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: a case report.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Delirium; Drug Therapy, Combination; Female; Humans; Lithium; Middle Aged; Olanzapine | 2005 |
Stevens-Johnson syndrome (SJS) leading to resolution of mania.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Lithium; Male; Olanzapine; Psychotic Disorders; Severity of Illness Index; Stevens-Johnson Syndrome; Surveys and Questionnaires; Treatment Outcome | 2006 |
[Humor in bipolar disorder].
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Humans; Lithium; Male; Olanzapine; Wit and Humor as Topic | 2005 |
Olanzapine-induced oculogyric crisis.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Benzodiazepines; Female; Humans; Lithium; Ocular Motility Disorders; Olanzapine | 2006 |
Effects of 4-week treatment with lithium and olanzapine on levels of brain-derived neurotrophic factor, B-cell CLL/lymphoma 2 and phosphorylated cyclic adenosine monophosphate response element-binding protein in the sub-regions of the hippocampus.
Topics: Animals; Benzodiazepines; Brain-Derived Neurotrophic Factor; Cyclic AMP Response Element-Binding Protein; Dentate Gyrus; Hippocampus; Lithium; Lithium Carbonate; Male; Olanzapine; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley | 2009 |
Treatment-resistant bipolar depression: towards a new definition.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Resistance; Evidence-Based Practice; Fluoxetine; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic | 2009 |
In search of optimal lithium levels and olanzapine doses in the long-term treatment of bipolar I disorder. A post-hoc analysis of the maintenance study by Tohen et al. 2005.
Topics: Antimanic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Female; Humans; Lithium; Logistic Models; Male; Olanzapine; Proportional Hazards Models; Recurrence; Risk Factors; Severity of Illness Index; Treatment Outcome | 2010 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
Predictors of relapse or recurrence in bipolar I disorder.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Humans; Lithium; Male; Middle Aged; Olanzapine; Prognosis; Recurrence; Valproic Acid | 2012 |
Comparably high retention and low relapse rates in different subpopulations of bipolar patients in a German non-interventional study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Female; Germany; Humans; Lithium; Male; Medication Adherence; Middle Aged; Olanzapine; Prospective Studies; Recurrence; Treatment Outcome; Young Adult | 2013 |
Phosphorylation of transcription factor specificity protein 4 is increased in peripheral blood mononuclear cells of first-episode psychosis.
Topics: Adolescent; Adult; Animals; Antipsychotic Agents; Benzodiazepines; Cells, Cultured; Cross-Sectional Studies; Female; Humans; Lithium; Male; Models, Biological; Neurons; Olanzapine; Phosphorylation; Pilot Projects; Psychotic Disorders; Rats; Serine; Sp4 Transcription Factor; Valproic Acid; Young Adult | 2015 |
Changes in mood stabilizer prescription patterns in bipolar disorder.
Topics: Adult; Aged; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Prescriptions; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Sweden; Valproic Acid | 2016 |
Do not treat the numbers: lithium toxicity.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diagnosis, Differential; Humans; Lithium; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Secondary Prevention; Treatment Outcome | 2017 |
Second-generation antipsychotic and diabetes mellitus in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Benzodiazepines; Blood Glucose; Clomipramine; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Insulin; Lithium; Male; Metformin; Olanzapine; Valproic Acid | 2017 |
Lithium is able to minimize olanzapine oxidative-inflammatory induction on macrophage cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Cell Proliferation; Cytokines; Inflammation; Lithium; Macrophages; Mice; Olanzapine; Oxidative Stress; RAW 264.7 Cells | 2019 |
Pica disorder as a symptom of depression in a patient with bipolar disorder and intellectual disability.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Depression; Female; Humans; Intellectual Disability; Lithium; Olanzapine; Pica; Topiramate | 2020 |
Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram.
Topics: Antipsychotic Agents; Bipolar Disorder; Citalopram; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Valproic Acid; Venlafaxine Hydrochloride | 2021 |
A safety signal of somnambulism with the use of antipsychotics and lithium: A pharmacovigilance disproportionality analysis.
Topics: Antipsychotic Agents; Humans; Lithium; Male; Olanzapine; Pharmacovigilance; Somnambulism | 2021 |
Effects of Psychotropic Drugs on Ribosomal Genes and Protein Synthesis.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Humans; Lithium; Olanzapine; Psychotropic Drugs; Quetiapine Fumarate; Ribosomes | 2022 |
Increased levels of lipid and protein oxidation in rat prefrontal cortex after treatment by lithium, valproic acid, and olanzapine.
Topics: Advanced Oxidation Protein Products; Animals; Antipsychotic Agents; Benzodiazepines; Lithium; Male; Olanzapine; Prefrontal Cortex; Rats; Rats, Wistar; Valproic Acid | 2023 |